Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered question first ministerially corrected answering member label attachment file name title previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1503297

	registered interest
	date	02/09/2022
	answering body	Department for Business, Energy and Industrial Strategy
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	hansard heading	Research, Development and Innovation Organisational Landscape Review
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, when he plans to publish the independent review of the research, development and innovation landscape.
	tabling member constituency	Sheffield Central
	tabling member printed	Paul Blomfield
	uin	44969
	answer	answer is ministerial correction date of answer 28/09/2022 answer text <p><del class="ministerial">The Department has no plans to make an assessment of the impact of the medical cannabis industry on the economy or employment levels. The Department annually publishes data on the impact on the economy and employment of the wider Life Sciences sector in the <a href="https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fcollections%2Fbioscience-and-health-technology-database-annual-reports&amp;data=05%7C01%7CRobert.Reid%40officeforlifesciences.gov.uk%7C52a0f4af72164a3b141608da90ba3996%7Ccbac700502c143ebb497e6492d1b2dd8%7C0%7C0%7C637981426767702174%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&amp;sdata=xG98g%2B1%2BBzW72DAM8Cpp8i%2FEn2ic5G1qf2ZbOzZsXXU%3D&amp;reserved=0" target="_blank">Bioscience and health technology sector statistics</a>, and this includes analysis of the bio-pharmaceuticals sector of which the medical cannabis industry is an important part.</del></p><p> </p><p><ins class="ministerial">In leading his independent Review of the Research, Development and Innovation Organisational Landscape, Sir Paul Nurse has gathered input from members of the Review’s Scoping Group and Sounding Board, alongside hundreds of organisations in the UK’s RDI landscape. Work is underway to consider and finalise the Review’s recommendations, which will consider input from those group members, ahead of the Review’s publication in the coming months.</ins></p> answering member constituency Wealden answering member printed Ms Nusrat Ghani question first answered 28/09/2022 09:25:52 question first ministerially corrected 03/10/2022 12:34:32 answering member 4460 label Biography information for Ms Nusrat Ghani previous answer version 20886 answering member constituency Wealden answering member printed Ms Nusrat Ghani answering member 4460 label Biography information for Ms Nusrat Ghani
	tabling member	4058 label Biography information for Paul Blomfield

1503298

	registered interest
	date	02/09/2022
	answering body	Department for Business, Energy and Industrial Strategy
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	hansard heading	Research, Development and Innovation Organisational Landscape Review
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, whether the (a) Scoping Group and (b) Sounding Board to the review of the research, development and innovation landscape will approve the recommendations of the Review.
	tabling member constituency	Sheffield Central
	tabling member printed	Paul Blomfield
	uin	44970
	answer	answer is ministerial correction date of answer 28/09/2022 answer text <p><del class="ministerial">The Department has no plans to make an assessment of the impact of the medical cannabis industry on the economy or employment levels. The Department annually publishes data on the impact on the economy and employment of the wider Life Sciences sector in the <a href="https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fcollections%2Fbioscience-and-health-technology-database-annual-reports&amp;data=05%7C01%7CRobert.Reid%40officeforlifesciences.gov.uk%7C52a0f4af72164a3b141608da90ba3996%7Ccbac700502c143ebb497e6492d1b2dd8%7C0%7C0%7C637981426767702174%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&amp;sdata=xG98g%2B1%2BBzW72DAM8Cpp8i%2FEn2ic5G1qf2ZbOzZsXXU%3D&amp;reserved=0" target="_blank">Bioscience and health technology sector statistics</a>, and this includes analysis of the bio-pharmaceuticals sector of which the medical cannabis industry is an important part.</del></p><p><ins class="ministerial">In leading his independent Review of the Research, Development and Innovation Organisational Landscape, Sir Paul Nurse has gathered input from members of the Review’s Scoping Group and Sounding Board, alongside hundreds of organisations in the UK’s RDI landscape. Work is underway to consider and finalise the Review’s recommendations, which will consider input from those group members, ahead of the Review’s publication in the coming months.</ins></p> answering member constituency Wealden answering member printed Ms Nusrat Ghani question first answered 28/09/2022 09:25:52 question first ministerially corrected 03/10/2022 12:34:22 answering member 4460 label Biography information for Ms Nusrat Ghani previous answer version 20889 answering member constituency Wealden answering member printed Ms Nusrat Ghani answering member 4460 label Biography information for Ms Nusrat Ghani
	tabling member	4058 label Biography information for Paul Blomfield

1276338

	registered interest
	date	13/01/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Global Health Insurance Card
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what the differences in coverage of (a) countries and (b) services are between the European Health Insurance Card scheme and the UK Global Health Insurance Card; and if he will make a statement.
	tabling member constituency	Sheffield Central
	tabling member printed	Paul Blomfield
	uin	137184
	answer	answer is ministerial correction date of answer 18/01/2021 answer text <p>The reciprocal healthcare coverage under the United Kingdom-European Union Trade and Cooperation Agreement for those on a temporary stay in an EU member state is the same, in terms of healthcare services which can be accessed by individuals, compared to the previous coverage under EU Regulations 883 and 987. However, under the UK-EU Trade and Cooperation Agreement, crew or passengers of a vessel or aircraft may now be covered for necessary healthcare on their arrival in an EU member state if the need arose whilst on a voyage, which is not the case under the EU Regulations.</p><p><ins class="ministerial">The UK-EU Trade and Cooperation Agreement provides reciprocal healthcare coverage for travel to EU member states only. European Free Trade Area states are not covered. The UK Global Health Insurance Card has been launched to recognise this new agreement and will gradually replace old European Health Insurance Cards (EHIC) once they expire. </ins></p><p><ins class="ministerial">Under the terms of the Withdrawal Agreement, UK nationals who were residing and/or working in the EU, and EU citizens residing and/or working in the UK, before 1 January 2021 are eligible to apply for a new UK EHIC which can be used for travel to EU member states, Switzerland, Norway, Iceland and Liechtenstein. For those who are not covered by the Withdrawal Agreement, the UK has agreed a bilateral reciprocal arrangement with Norway which means UK nationals are covered for necessary healthcare there.</ins></p><p> </p> answering member constituency Charnwood answering member printed Edward Argar question first answered 18/01/2021 17:30:43 question first ministerially corrected 24/03/2021 11:09:28 answering member 4362 label Biography information for Edward Argar previous answer version 74914 answering member constituency Charnwood answering member printed Edward Argar answering member 4362 label Biography information for Edward Argar
	tabling member	4058 label Biography information for Paul Blomfield

1130501

	registered interest
	date	06/06/2019
	answering body	Home Office
	answering dept id	1
	answering dept short name	Home Office
	answering dept sort name	Home Office
	hansard heading	Immigration: EU Nationals
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for the Home Department, pursuant to the Answer of 20 May 2019 to Question 254185 on Immigration: EU Nationals, if he will place in the Library, a copy of the algorithm applied by his Department during automated residency checks.
	tabling member constituency	Sheffield Central
	tabling member printed	Paul Blomfield
	uin	261208
	answer	answer is ministerial correction date of answer 11/06/2019 answer text <p>Guidance on the automated checks process has been published on gov.uk and a copy of this will be placed in the Library. <br /><a href="https://www.gov.uk/guidance/eu-settlement-scheme-uk-tax-and-benefits-records-automated-check." target="_blank">https://www.gov.uk/guidance/eu-settlement-scheme-uk-tax-and-benefits-records-automated-check.</a></p><p>The rules for assessing continuous residence are already set out in the Immigration Rules. The automated checks simply apply these principles to the data provided by Her Majesty's Revenue and Customs and The Department for Work and Pensions. The automated checks replace the need, where data exists, for an applicant to submit any other forms of evidence.</p> answering member constituency Romsey and Southampton North answering member printed Caroline Nokes question first answered 11/06/2019 11:11:01 question first ministerially corrected 11/06/2019 11:31:13 answering member 4048 label Biography information for Caroline Nokes attachment 1 file name How_the_automated_check_calculates_the_period_of_residence.docx title The Automated Checks - EU Settlement Scheme previous answer version 121701 answering member constituency Romsey and Southampton North answering member printed Caroline Nokes answering member 4048 label Biography information for Caroline Nokes
	tabling member	4058 label Biography information for Paul Blomfield

1195660

	registered interest
	date	13/05/2020
	answering body	Department for Work and Pensions
	answering dept id	29
	answering dept short name	Work and Pensions
	answering dept sort name	Work and Pensions
	hansard heading	Universal Credit: Coronavirus
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Work and Pensions, what assessment she has made of the effect of the decision not to extend the covid-19 emergency £20 funding for universal credit claimants to those on legacy benefits.
	tabling member constituency	Sheffield Central
	tabling member printed	Paul Blomfield
	uin	46632
	answer	answer is ministerial correction date of answer 05/06/2020 answer text <p>As part of the Government’s strategy to support people affected by COVID 19, DWP has made a number of changes to make sure people can self-isolate, and to ensure people who need financial help have access to the benefit system. We have announced measures that benefit those experiencing the most financial disruption and which can be quickly and effectively operationalised, these include:</p><p> </p><ul><li>Increasing the Local Housing Allowance rates so that they cover 30% of local market rents – which is on average an additional £600 per year in people’s pockets.</li></ul><p> </p><ul><li>Amendments to Housing Benefit so that increases in Working Tax Credits can be disregarded rather than reducing the Housing Benefit award.</li></ul><p> </p><ul><li><strong> </strong>Treating all ESA claimants who satisfy the conditions of entitlement and are suffering from COVID-19, or who are required to self-isolate in line with government guidance, as having limited capability for work, without the requirement to provide a fit note or to undergo a Work Capability Assessment.</li></ul><p> </p><ul><li>Removing waiting days for ESA for those claimants affected by Covid-19, so it will be payable from day one of the claim, subject to the claimant satisfying the normal conditions of entitlement.</li></ul> answering member constituency Colchester answering member printed Will Quince question first answered 05/06/2020 11:24:12 answering member 4423 label Biography information for Will Quince previous answer version 22282 answering member constituency Colchester answering member printed Will Quince answering member 4423 label Biography information for Will Quince
	tabling member	4058 label Biography information for Paul Blomfield

1503999

	registered interest
	date	02/09/2022
	answering body	Home Office
	answering dept id	1
	answering dept short name	Home Office
	answering dept sort name	Home Office
	hansard heading	Seasonal Workers: Ukraine
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for the Home Department, what immigration options to remain in the UK beyond the end of (a) September and (b) December 2022 will be available to Ukrainian Seasonal Worker visa holders who entered the UK after 18 March 2022; and whether those visa holders will be required to leave the UK and apply for a separate visa to re-enter the UK.
	tabling member constituency	Sheffield Central
	tabling member printed	Paul Blomfield
	uin	45788
	answer	answer is ministerial correction date of answer 08/09/2022 answer text <p>Following the Russian incursion into Ukraine, the Home Office quickly created the Ukraine Extension Scheme to support Ukrainian nationals who were already lawfully in the UK on visas that had or may expire.</p><p> </p><p>These Ukrainian nationals are able to extend their permission to stay to 36 months. In line with the two other Ukraine schemes, and have all the rights and access to benefits in line with those schemes.</p><p> </p><p>The Home Office is constantly keeping these schemes under review.</p> answering member constituency Corby answering member printed Tom Pursglove question first answered 08/09/2022 16:56:02 answering member 4369 label Biography information for Tom Pursglove previous answer version 17762 answering member constituency Corby answering member printed Tom Pursglove answering member 4369 label Biography information for Tom Pursglove
	tabling member	4058 label Biography information for Paul Blomfield

1504062

	registered interest
	date	02/09/2022
	answering body	Department for Levelling Up, Housing and Communities
	answering dept id	211
	answering dept short name	Levelling Up, Housing and Communities
	answering dept sort name	Levelling Up, Housing and Communities
	hansard heading	Homes for Ukraine Scheme
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Levelling Up, Housing and Communities, whether it is his policy to increase the level of funding local authorities receive for each person on the Homes for Ukraine scheme, in the context of the decision to extend payments to hosts to up to 12 months.
	tabling member constituency	Sheffield Central
	tabling member printed	Paul Blomfield
	uin	45623
	answer	answer is ministerial correction date of answer 21/09/2022 answer text <p>We are overwhelmed by the response we have received to the Homes for Ukraine programme and thank sponsors for their support. Lead sponsors can receive monthly £350 ‘thank you’ payments for up to 12 months of Homes for Ukraine sponsorship per address. These payments are funded separately to the £10,500 of funding available to local authorities for 12 months per person.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 48297 48465 question first answered 21/09/2022 16:15:17 answering member 4044 label Biography information for Andrew Stephenson previous answer version 17708 answering member constituency Sutton and Cheam answering member printed Paul Scully answering member 4414
	tabling member	4058 label Biography information for Paul Blomfield

1186203

	registered interest
	date	18/03/2020
	answering body	Department for Education
	answering dept id	60
	answering dept short name	Education
	answering dept sort name	Education
	hansard heading	Pupils: Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Education, what assessment he has made of the effect on school pupils’ performance and wellbeing of financial stress in their families.
	tabling member constituency	Sheffield Central
	tabling member printed	Paul Blomfield
	uin	31500
	answer	answer is ministerial correction date of answer 08/04/2020 answer text <p>The Government recognises that, for many complex reasons, economic disadvantage can have an adverse effect on pupil attainment and wellbeing.</p><p>Through the pupil premium, the Department has spent more than £18 billion since 2011, including £2.4 billion in 2019-20, to tackle educational inequality. We established the Education Endowment Fund with £137 million to research and promote the most effective ways of using pupil premium funding so that all schools can make a difference to the futures of their disadvantaged pupils. Since 2011, the attainment gap between disadvantaged pupils and their peers has decreased at both ages 11 and 16.</p><p>The Department has taken a range of actions to help schools support the mental wellbeing of their pupils. This includes teaching pupils about mental wellbeing through the introduction of health education and improving collaboration with external agencies to ensure those pupils that need specialist support and treatment get it quickly. New Mental Health Support Teams (MHSTs) will be established in 20% to 25% of the country by 2023, supporting children and young people with mild to moderate mental health issues, and helping those with more severe needs to access the right specialist services locally. MHSTs should be delivered in a way to take account of disadvantage and seek to reduce health inequalities. We will also fund training for senior mental health leads in every state funded school and college in England, providing the skills and knowledge required to put in place effective whole school and college approaches to promote and support good mental health. We also have several initiatives in place to further support schools to develop and implement whole school approaches to mental health and wellbeing.</p> answering member constituency Bognor Regis and Littlehampton answering member printed Nick Gibb question first answered 08/04/2020 16:39:48 answering member 111 label Biography information for Nick Gibb previous answer version 14153 answering member constituency Bognor Regis and Littlehampton answering member printed Nick Gibb answering member 111 label Biography information for Nick Gibb
	tabling member	4058 label Biography information for Paul Blomfield

1221068

	registered interest
	date	06/07/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Clinical Trials: Standards
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that (a) clinical trials and (b) market authorisations from the UK’s Medicines and Healthcare products Regulatory Agency comply with European Medicines Agency standards in order to obtain approval for use in the EU market.
	tabling member constituency	Sheffield Central
	tabling member printed	Paul Blomfield
	uin	69522
	answer	answer is ministerial correction date of answer 20/07/2020 answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) has taken pragmatic steps to ensure that the United Kingdom continues to have innovative and cost-effective treatments that benefit patients and boost growth in the life sciences sector. This includes limiting any additional cost or burden on industry by considering applications for marketing authorisations in the UK on the basis of information consistent with that being submitted to the European Medicines Agency (EMA).</p><p>As for clinical trials, the MHRA will continue to approve applications at a national level, working to international standards as they are now, using a UK data package whose requirements are consistent with those in the European Union. The UK will still have the ability to participate in multinational trials, as, data generated in a UK clinical trial will continue to be admissible to support regulatory activity in the EU, and indeed globally. This ensures the UK remains an attractive location for trials to take place, with a view to getting medicinal products licensed in the UK and elsewhere.</p><p> </p> answering member constituency Mid Bedfordshire answering member printed Ms Nadine Dorries question first answered 20/07/2020 13:30:07 answering member 1481 label Biography information for Ms Nadine Dorries previous answer version 36157 answering member constituency Mid Bedfordshire answering member printed Ms Nadine Dorries answering member 1481 label Biography information for Ms Nadine Dorries
	tabling member	4058 label Biography information for Paul Blomfield

1276881

	registered interest
	date	14/01/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to produce and publish additional evidence on assessing the use of the Pfizer-BioNTech, AstraZeneca and Moderna covid-19 vaccines for pregnant and breastfeeding women.
	tabling member constituency	Sheffield Central
	tabling member printed	Paul Blomfield
	uin	137915
	answer	answer is ministerial correction date of answer 25/01/2021 answer text <p>There are currently no plans to produce and publish additional evidence regarding the use of COVID-19 vaccines on pregnant or breastfeeding women. It is recommended to that women affected should discuss whether to receive the vaccine with their doctor, pharmacist or nurse.</p> answering member constituency Mid Bedfordshire answering member printed Ms Nadine Dorries question first answered 25/01/2021 17:51:20 answering member 1481 label Biography information for Ms Nadine Dorries previous answer version 75377 answering member constituency Mid Bedfordshire answering member printed Ms Nadine Dorries answering member 1481 label Biography information for Ms Nadine Dorries
	tabling member	4058 label Biography information for Paul Blomfield